What is AptarGroup's pharma — net revenue?

AptarGroup (ATR) reported pharma — net revenue of $438.56M in Q1 2026.

How has AptarGroup's pharma — net revenue changed year-over-year?

AptarGroup's pharma — net revenue increased by 7.1% year-over-year, from $409.47M to $438.56M.

What does pharma — net revenue mean?

The total income generated from the sale of dispensing systems to the pharmaceutical, injectables, and healthcare markets, after deducting returns, allowances, and discounts. It serves as the primary indicator of the segment's market demand and competitive performance.

AptarGroup ATR Pharma — Net revenue

Discontinued — last reported Q1 '26

Similar metrics at other companies

VRTXPharmaceuticals — Product revenues, net

$2.99B+7.8%

BAXPharmaceuticals — Net Sales

$621M+6.9%

VRTXProduct revenues, net — Product revenues, net

$2.99B+8.2%

BMYNet product sales — Total Revenues

$11.17B+2.6%

BIIBProduct revenue, net — Total Revenue

$1.75B+1.5%

REGNProduct — Revenue

$1.53B+8.4%

Other financials

Income statement

See full

Revenue$982.9M+10.8%

Gross profit$351.9M+4.6%

Operating income$107.5M-5.2%

Net income$72.7M-7.8%

EPS (diluted)$1.12-4.3%

Balance sheet

See full

Cash & equivalents$225.0M+78.8%

Total debt$1.4B+32.7%

Total equity$2.6B+3.6%

Total assets$5.1B+12.6%

Cash flow

See full

Operating cash flow$118.7M+43.5%

CapEx$65.4M+15.0%

Free cash flow$53.3M+106%

Valuation

See full

Market cap$7.68B-17.9%

Enterprise value$8.89B-13.9%

P/E19.9×-5.4×

P/S2×-0.6×

Profitability

See full

Gross margin36.7%-1.6pp

Operating margin12.8%-1.2pp

Net margin10%-0.4pp

FCF margin8.4%-2.1pp

Returns & leverage

See full

Return on equity15%-0.2pp

Debt / equity0.5×+0.1×

Current ratio1.7×+0.4×

Where this comes from

Reported directly by AptarGroup in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.

The official record: AptarGroup’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about AptarGroup's pharma — net revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is AptarGroup's pharma — net revenue?: AptarGroup (ATR) reported pharma — net revenue of $438.56M in Q1 2026.
How has AptarGroup's pharma — net revenue changed year-over-year?: AptarGroup's pharma — net revenue increased by 7.1% year-over-year, from $409.47M to $438.56M.
What does pharma — net revenue mean?: The total income generated from the sale of dispensing systems to the pharmaceutical, injectables, and healthcare markets, after deducting returns, allowances, and discounts. It serves as the primary indicator of the segment's market demand and competitive performance.